Tolerance and Effectiveness of C14 on HPV Infection

Clinical trial NCT06672653 · NOT_YET_RECRUITING

Trial details

NCT number: NCT06672653
Sponsor: MGB Pharma
Status: NOT_YET_RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

HPV-induced Cancers HPV Infections HIV Cervical Cancers Trial C14 Monoterpenoid Zinc Tetra-ascorbo-camphorate

Start date: 2024-11-15
Primary completion: 2025-03-15
Enrollment: 66

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.